Koniku develops hybrid bioelectronic sensing systems that integrate live biological neurons with silicon chips to detect chemical compounds, pathogens, explosives, and other substances. The company's flagship product, Konikore, uses engineered neurons with olfactory receptors fused to silicon hardware and has been deployed in applications spanning airport security, healthcare diagnostics, food quality assurance, and threat detection. Founded in 2015 by Osh Agabi, Koniku is based in California and has partnered with Airbus since 2017 on aviation security systems and became a founding member of Oracle Corporation's Defense Ecosystem in 2025. The company's technology relies on programming living neurons via DNA sequences to create specific receptors, converting bioelectric signals into digital outputs; neurons remain functional for up to two years in nutritive cartridges. Koniku has raised funding from investors including SoftBank and conducted clinical testing of its sensing technology during the COVID-19 pandemic in collaboration with Treximo and the University of Southern Nevada.